GW 4064

GW 4064 is a synthetic small molecule selective agonist of the orphan nuclear receptor FXR (EC50=15nM) developed by GlaxoSmithKline. Protects cells and organs against bile acid toxicity, and used to elucidate FXR's role in dyslipidemia, diabetes, obesity, and cancer. Has no activity against other nuclear receptors.

Catalog No. Size Price Quantity
92-1129 10 mg $318.00

Please contact Customer Service at customerservicedrx@eurofins.com for European (EUR) or United Kingdom (GBP) pricing or log in to see your account-specific pricing.
Description
GW 4064
Compound Type
Agonist
Storage
2-8◦C
Source
Synthetic
The above data is a representative example from a Eurofins DiscoverX cell-based assay that uses this ligand.